Is FMC Corporation (FMC) overvalued or fairly valued?

MarketChacha shows FMC Corporation's valuation in context — a forward P/E of about 5.7, a price-to-book of about 0.8 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is FMC Corporation's revenue?

FMC Corporation reported revenue of $3.5B for FY2025, with net profit of $-2.2B, per official filings.

What is the share price of FMC Corporation (FMC)?

FMC Corporation last traded at $11.75 (+3.3% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

FMC Corporation

FMC · NYSE · Materials · United States

$11.75+3.3%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 7:28 PM

Snapshot

TickerFMC

ExchangeNYSE

SectorMaterials

IndustryAgricultural Inputs

CountryUnited States

Employees5,500

HeadquartersPhiladelphia, United States

Market cap$1.5B

P/B0.8

Volume2.09M

Websitewww.fmc.com

Filings tracked10

About FMC Corporation

FMC Corporation, an agricultural sciences company, develops, markets, and sells crop protection chemicals in Latin America, North America, Europe, the Middle East, Africa, and Asia. The company offers crop protection chemicals, including insecticides, herbicides, and fungicides. It also provides biologicals, crop nutrition, and seed treatment products. It markets its products through its sales organization and alliance partners, independent distributors, and sales representatives. The company was founded in 1883 and is headquartered in Philadelphia, Pennsylvania.

Profile as reported by Yahoo Finance.

Who owns it

Insiders0.9%
Institutions95.8%
Public & other3.3%

577 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.14.95%
AQR Capital Management, LLC7.41%
Vanguard Portfolio Management LLC6.16%
Shaw D.E. & Co., Inc.4.81%
Vanguard Capital Management LLC4.61%
State Street Corporation3.84%
Morgan Stanley2.72%
Two Sigma Investments, LP1.90%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

Forensic scorecard

Margin has compressed by about 94.0 points over the period — profitability is trending down.

Net margin trend29.5% → -64.6%

Margin has compressed by about 94.0 points over the period — profitability is trending down.

Return on equity-108.1%

Latest ROE of -108.1% is on the low side — the business earns a modest return on shareholder capital.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $950.4M · EPS 0.64

Est. earnings growth -28.5%

Next fiscal year

Rev $3.9B · EPS 2.05

Est. earnings growth +23.2%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$10.5652-wk range$43.97

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Market cap

$1.5B

Day change

+3.3%

Fwd P/E

5.7

P/B

0.8

Div yield

2.81%

Beta

0.39

Revenue (FY2025)

$3.5B

Net margin

-64.6%

ROE

-108.1%

Revenue CAGR (2y)

-12.1%

EPS (FY2025)

-17.88

Net profit (FY2025)

$-2.2B

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about FMC

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$3.5B	$-2.2B	-17.88	-64.6%	-108.1%
FY2024	$4.2B	$341.1M	2.72	8.0%	7.6%
FY2023	$4.5B	$1.3B	10.53	29.5%	30.0%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q1	$758.6M	$-281.3M	-2.25	-37.1%
2025Q4	$1.1B	$-1.7B	-13.74	-158.8%
2025Q3	$542.2M	$-569.3M	-4.52	-105.0%
2025Q2	$1.1B	$66.7M	0.53	6.3%
2025Q1	$791.4M	$-15.5M	-0.12	-2.0%
2024Q4	$1.2B	$-16.3M	-0.13	-1.3%
2024Q3	$1.1B	$65.0M	0.52	6.1%
2024Q2	$1.0B	$295.1M	2.35	28.4%
2024Q1	$918.0M	$-2.7M	-0.02	-0.3%
2023Q4	$1.1B	$1.1B*	8.77	—
2023Q3	$981.9M	$-3.5M	-0.03	-0.4%
2023Q2	$1.0B	$30.5M	0.24	3.0%
2023Q1	$1.3B	$196.0M	1.55	14.6%

* Net profit includes one-off / non-operating items (e.g. a settlement or accounting gain), so it doesn’t reflect operating performance — net margin is hidden for that period.

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

8-K — Material agreement, Unregistered equity sale, Reg FD disclosure, Exhibits
SEC7/1/2026material
8-K — Material agreement, Exhibits
SEC6/23/2026material
8-K — Material agreement, Material financial obligation, Exhibits
SEC6/23/2026material
8-K — Material agreement, Material financial obligation, Exhibits
SEC6/5/2026material
8-K — Other events, Exhibits
SEC5/21/2026material
8-K — Other events, Exhibits
SEC5/19/2026material
10-Q filing
SEC4/30/2026
8-K — Results of operations, Exhibits
SEC4/29/2026material
8-K — Executive/director change, Bylaw/charter change, Shareholder vote results, Exhibits
SEC4/29/2026material
8-K — Material agreement, Material financial obligation, Exhibits
SEC4/20/2026material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.